Education
About Us
Working with TipRanks
Follow Us
Rapt Therapeutics Inc (RAPT)
NASDAQ:RAPT
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 1.53M | $ 3.81M | $ 5.04M |
| Gross Profit | $ 0.00 | $ 0.00 | $ 1.53M | $ 3.81M | $ 5.04M |
| Operating Income | $ -136.10M | $ -127.06M | $ -85.80M | $ -69.21M | $ -53.21M |
| EBITDA | $ -134.90M | $ -125.85M | $ -84.75M | $ -68.21M | $ -52.09M |
| Net Income | $ -129.87M | $ -116.80M | $ -83.84M | $ -69.20M | $ -52.89M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 231.06M | $ 158.86M | $ 249.07M | $ 189.65M | $ 111.51M |
| Total Assets | $ 240.32M | $ 173.33M | $ 266.21M | $ 198.64M | $ 118.97M |
| Total Debt | $ 4.49M | $ 6.91M | $ 8.99M | $ 0.00 | $ 0.00 |
| Net Debt | $ -165.24M | $ -40.57M | $ -29.96M | $ -24.03M | $ -24.92M |
| Total Liabilities | $ 50.42M | $ 26.29M | $ 21.04M | $ 12.26M | $ 14.79M |
| Stockholders' Equity | $ 189.90M | $ 147.03M | $ 245.17M | $ 186.38M | $ 104.18M |
| Cash Flow | |||||
| Free Cash Flow | $ -83.42M | $ -98.17M | $ -71.62M | $ -61.78M | $ -40.89M |
| Operating Cash Flow | $ -83.30M | $ -97.05M | $ -70.77M | $ -61.03M | $ -40.49M |
| Investing Cash Flow | $ 52.70M | $ 104.13M | $ -45.49M | $ -81.35M | $ -87.44M |
| Financing Cash Flow | $ 152.85M | $ 1.45M | $ 131.18M | $ 141.48M | $ 75.46M |
RAPT Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.